Dyne Therapeutics

Associate Director, Formulation and Drug Product Development

Dyne Therapeutics$159K — $195K *
Pharmaceuticals & Biotech
8 - 10 years of experience
Job Overview by Ladders

Qualifications

  • PhD or equivalent in a scientific discipline with 8+ years relevant experience.
  • Proven expertise in clinical drug product formulation, including lyophilization and injectables.
  • Extensive knowledge of sterile fill-finish manufacturing and supporting analytical techniques.
  • Strong understanding of cGMP manufacturing requirements and processes.
  • Proficiency in managing complex schedules in a dynamic biotech setting.
  • Demonstrated ability to influence and achieve consensus within cross-functional teams.
  • Resilient work ethic capable of thriving in fast-paced environments.

Responsibilities

  • Serve as the drug product development expert within Technical Development.
  • Act as the primary contact for CDMO(s) on formulation development activities.
  • Develop and enhance internal formulation capabilities in the lab.
  • Oversee tech transfer and scale-up of drug product processes in cGMP settings.
  • Contribute to clinical filing documentation (INDs/IMPDs).
  • Ensure continuity of drug supply through collaboration with various departments.
  • Lead the execution of formulation development plans with CDMO partners.

Benefits

  • Opportunities for professional growth and development.
  • Collaborative work culture fostering teamwork and innovation.
  • Engagement with cutting-edge projects in bioconjugate drug development.
  • Structured support for maintaining a strong work-life balance.
  • Commitment to ethical practices and quality results.
Full Job Description
Role Summary:

The Associate Director, Formulation and Drug Product Development will be accountable for all internal and external activities related to successful formulation development for Dyne's bioconjugate drug products to ensure favorable manufacturability, product quality, and long-term stability. This role will partner closely with colleagues in Research, Pharmaceutical Quality, and Manufacturing to define Dyne's strategy for bringing best-in-class medicines to patients in need, including high-concentration formulations for subcutaneous administration and lyophilized drug products to ensure seamless supply of all drug products for clinical trials.

This role is based in Waltham, MA without the possibility of being a remote role. Physical presence onsite is expected on 4-5 days/week.

Primary Responsibilities Include:
  • Act as the subject matter expert for drug product development within the Technical Development group, including formulation development, selection of container closure systems, and sterile fill finish clinical manufacturing.
  • Act as main point of contact for CDMO(s) for external formulation development activities, and liaise with the Research group to define, streamline and execute early-stage formulation development efforts.
  • Build and enhance internal capabilities for formulation development in the laboratory.
  • Responsible for development, tech transfer, and scale-up of drug product processes, and cGMP manufacturing of clinical grade drug product (Phase 1-3).
  • Key contributor to drug product sections of early-stage clinical filings (INDs/IMPDs/Health Canada).
  • Collaborate with Technical Development, Manufacturing, Quality Control, Quality Assurance, and Regulatory Affairs to ensure continuity of drug supply for early clinical evaluation.
  • Responsible for driving execution of the formulation development plan at CDMO (PO through delivery).
  • Champion a strong winning culture, fostering teamwork and commitment to excellence through transparent communication, engagement and collaboration.

Education and Skills Requirements:
  • PhD or equivalent experience in a scientific discipline and a minimum of 8+ years related experience.
  • Proven experience in clinical drug product formulation development including liquid fill finish, lyophilization, subcutaneous formulations, and other injectables.
  • Expertise in sterile fill-finish early clinical manufacturing as well as understanding of analytical techniques that support manufacturing activities.
  • Demonstrated understanding of the principles and applications associated with external manufacturing operations from development to clinical manufacturing.
  • Strong experience and knowledge of cGMP manufacturing requirements.
  • Strategic thinker with a sense of urgency to deliver quality results on time and in a highly ethical and professional manner.
  • Experience managing complex schedules and priorities in a dynamic biotech environment.
  • Ability to work, influence, and gain consensus across multiple functions (Technical Operations, Quality and Regulatory Affairs).
  • Collaborative work style to be part of a team to identify process gaps and constructively develop solutions.
  • Excellent interpersonal, verbal, and written communication skills with the ability to establish strong cross-functional relationships.
  • Resilient and able to work in a demanding, fast-paced environment and capable of supporting multiple programs and vendors.


#LI-Onsite

MA Pay Range

$159,000-$195,000 USD

The pay range reflects the base pay range Dyne reasonably expects to pay for this role at the time of posting. Individual compensation depends on factors such as education, experience, job-related knowledge, and demonstrated skills.

The statements contained herein reflect general details as necessary to describe the principles functions for this job, the level of knowledge and skill typically required, and the scope of responsibility, but should not be considered an all-inclusive listing of work requirements. Individuals may perform other duties as assigned, including work in other functional areas to cover absences or relief, to equalize peak work periods or otherwise balance workload.

About Dyne Therapeutics

Dyne Therapeutics is a biotechnology company that is focused on developing therapies for patients with genetically driven muscle diseases. The company is developing a platform that is designed to deliver nucleic acids to muscle tissue. Dyne's lead product candidate is DYN101, which is a treatment for patients with myotonic dystrophy type 1 (DM1). DM1 is a genetic disorder that affects the muscles and other body systems. DYN101 is designed to reduce the levels of toxic RNA that are produced by the mutated gene that causes DM1. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.
Learn more about Dyne Therapeutics
Size
70 employees
Market Cap
$633.4 million
Industry
NASDAQ

Similar Jobs

More Jobs at Dyne Therapeutics

More Pharmaceuticals & Biotech Jobs

Find similar Associate Director, Formulation and Drug Product Development jobs: